Subcutaneous bone formation in the naevoid basal-cell carcinoma syndrome: normal urinary cyclic AMP response to parathyroid hormone infusion.
A patient with the naevoid basal-cell carcinoma syndrome had subcutaneous bone formation in the areas other than those occupied by the carcinomata. The patient did not show a significant phosphaturic response after parathyroid hormone infusion, but this extract produced a normal excretion of cyclic AMP. This proves that the subcutaneous bone does not signify an affinity to pseudo-hypoparathyroidism.
D000328:Adult; D001845:Bone Cysts / Q000150:complications* / Q000652:urine; D002118:Calcium / Q000008:administration & dosage; D002280:Basal Cell Carcinoma / Q000150:complications* / Q000473:pathology / Q000652:urine; D003404:Creatinine / Q000652:urine; D000242:Cyclic AMP / Q000652:urine*; D006801:Humans; D007571:Jaw Diseases / Q000150:complications* / Q000652:urine; D008297:Male; D009999:Ossification, Heterotopic / Q000150:complications* / Q000473:pathology; D010281:Parathyroid Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D010710:Phosphates / Q000652:urine; D012272:Ribs / Q000002:abnormalities*; D012535:Scalp / Q000473:pathology; D013577:Syndrome
D010281:Parathyroid Hormone; D010710:Phosphates; D003404:Creatinine; D000242:Cyclic AMP; D002118:Calcium